Filing Flows › Orthofix Medical (OFIX) › Q3 FY26
Orthofix Medical (OFIX) Q3 FY26 earnings results (third quarter fiscal 2026)
10-Q filed Nov 9, 2026
Orthofix Medical (OFIX) reported revenue of $208M for the third quarter fiscal 2026 (Q3 FY26), +1% from a year earlier and -1% from the quarter before. Operating margin was 0.7%, net loss $6.1M (2.9% of revenue).
Orthofix Medical, Q3 FY26: revenue $208M (+1% year over year), operating margin 0.7%, net loss $6.1M, operating cash flow $363K. The chart follows the revenue to costs, profit and cash.
| Q3 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $208M | -1% | +1% |
| Operating profit | $1.5M | — | — |
| Net earnings | −$6.1M | — | — |
| Operating cash flow | $363K | — | -97% |
What changed
Revenue was $207.9M in Q3 FY26, up 1% year over year and down 1% from the previous quarter. Global Spine was the largest line at 82% of revenue. Global Limb Reconstruction added $2.8M year over year (up 8%), 128% of the total change.
Gross margin was 70.5%, down 1.7 points from Q3 FY25. Operating profit was $1.5M, a 0.7% margin (up 9.0 points year over year). Operating expenses fell 12% while revenue rose 1%. The fastest-growing cost line was Other operating costs (+63%). The quarter ended with a net loss of $6.1M, narrower than the previous quarter's $15.8M loss. Net interest and other expense of $6.8M was the main reason.
Operating cash flow was $363K (down 97% year over year). Non-cash charges added back $13.2M of depreciation and amortization and $6.7M of share-based compensation. Working capital and other items used $13.5M. Capital expenditures of $14.5M exceeded it, leaving free cash flow of −$14.1M.
Questions
What was Orthofix Medical's revenue in the third quarter fiscal 2026?
Orthofix Medical (OFIX) reported revenue of $208M for the third quarter fiscal 2026 (Q3 FY26), +1% from a year earlier and -1% from the quarter before.
Was Orthofix Medical profitable in the third quarter fiscal 2026?
Operating profit was $1.5M (0.7% of revenue) and net loss $6.1M.
Source: Orthofix Medical 10-Q on SEC EDGAR.